COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is investigating ramatroban in addition to standard of care for hospitalized COVID-19 pneumonia patients; t…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial investigating low-dose radiation therapy for severe COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients. [Phase 2, Phase 3]
A clinical trial update assessing the efficacy of megadose vitamin C in severe and critical COVID-19 patients (Phase 2/Phase 3). No results …
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia [Phase 3]
Phase 3 trial exploring UC-MSCs for severe and critical COVID-19 with refractory hypoxia; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia. [Phase 2]
Phase 2 trial update on the efficacy and safety of Jaktinib in patients with COVID-19 pneumonia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients [Phase 3]
Phase 3 clinical trial exploring UC-MSCs for severe and critical COVID-19 patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia [Phase 1, Phase 2]
A clinical trial update for AstroStem-V in COVID-19 pneumonia across Phase 1 and Phase 2, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial update evaluating NestaCell mesenchymal stem cells for severe COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19) [Phase 4]
Phase 4 clinical trial update on Kesuting Syrup for COVID-19 pneumonia and cough has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: ANTIcoagulation in Severe COVID-19 Patients [Phase 2]
Phase 2 trial update on anticoagulation in patients with severe COVID-19 pneumonia; status completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection [Phase 2]
Phase 2 clinical trial investigating icatibant for COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia [Phase 3]
Clinical trial update on convalescent plasma for severe COVID-19 pneumonia, completed Phase 3 study.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Defibrotide in COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating defibrotide in patients with COVID-19 pneumonia completed.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients [Phase 2, Phase 3]
A completed phase 2/3 trial investigating the effectiveness and safety of an isothymol or carvacrol compound for COVID-19 patients.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients [Phase 3]
Phase 3 trial update evaluating high-dose methylprednisolone for COVID-19 pneumonia completed.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia [Phase 3]
Phase 3 trial assessing intravenous almitrine to reduce mechanical ventilation needs in hypoxemic respiratory failure from Covid-19 pneumoni…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Nebulised Heparin in Patients With COVID-19 Pneumonia [Phase 2, Phase 3]
Clinical trial update for nebulised heparin in COVID-19 pneumonia spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Study of Efficacy and Safety of MAS825 in Patients With COVID-19 [Phase 2]
Phase 2 clinical trial of MAS825 for COVID-19 pneumonia with impaired respiratory function has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia [Phase 3]
Phase 3 trial update for leronlimab in moderately ill COVID-19 pneumonia patients; study status is suspended.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation [Phase 3]
Phase 3 trial of leronlimab in COVID-19 pneumonia patients requiring mechanical ventilation or ECMO is suspended.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Efficacy of PJS-539 for Adult Patients With COVID-19. [Phase 2]
Phase 2 trial assessing the efficacy of PJS-539 in adults with COVID-19 and COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia [Phase 2]
Phase 2 trial completed evaluating safety and effect of STC3141 continuous infusion in severe COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intravenous allogeneic adipose-derived mesenchymal stem cells for safety and efficacy in severe COVID-19 pneumo…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury [Phase 2]
Phase 2 clinical trial evaluating CERC-002 for adults with COVID-19 pneumonia and acute lung injury has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19 [Phase 2, Phase 3]
Open-label, randomized study comparing intravenous pamrevlumab to standard of care in COVID-19 patients; study phases 2 and 3 have completed…